TY - JOUR
T1 - Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism
T2 - Analysis of surgical outcome
AU - on behalf of JPAS/JRAS Study Group
AU - Kobayashi, Hiroki
AU - Nakamura, Yoshihiro
AU - Abe, Masanori
AU - Kurihara, Isao
AU - Itoh, Hiroshi
AU - Ichijo, Takamasa
AU - Takeda, Yoshiyu
AU - Yoneda, Takashi
AU - Katabami, Takuyuki
AU - Tsuiki, Mika
AU - Wada, Norio
AU - Ogawa, Yoshihiro
AU - Sakamoto, Ryuichi
AU - Kawashima, Junji
AU - Sone, Masakatsu
AU - Inagaki, Nobuya
AU - Yoshimoto, Takanobu
AU - Yamada, Tetsuya
AU - Okamoto, Ryuji
AU - Matsuda, Yuichi
AU - Fujita, Megumi
AU - Watanabe, Minemori
AU - Tamura, Kouichi
AU - Tanabe, Akiyo
AU - Naruse, Mitsuhide
N1 - Publisher Copyright:
© 2020 European Society of Endocrinology Printed in Great Britain
PY - 2020
Y1 - 2020
N2 - Objectives: We investigated the clinical significance of ACTH stimulation during adrenal venous sampling (AVS) by surgical outcome of primary aldosteronism (PA). Design: Multicenter retrospective study by Japan PA study. Method: We allocated 314 patients with both basal and ACTH-stimulated AVS data who underwent adrenalectomy to three groups: basal lateralization index (LI) ≥2 with ACTH-stimulated LI ≥4 on the ipsilateral side (Unilateral (U) to U group, n = 245); basal LI <2 with ACTH-stimulated LI ≥4 (Bilateral (B) to U group, n = 15); and basal LI ≥2 with ACTH-stimulated LI <4 (U to B group, n = 54). We compared surgical outcomes among the groups using the Primary Aldosteronism Surgical Outcome (PASO) criteria. Results: Compared with U to U group, U to B group had poor clinical and biochemical outcomes and low rates of adrenal adenoma as pathological findings (P = 0.044, 0.006, and 0.048, respectively), although there were no significant differences between U to U and B to U groups. All patients in U to B group with clinical and biochemical benefits, however, had adrenal adenoma as pathological findings and could be well differentiated from those with poor surgical outcomes via basal LI (>8.3), but not ACTH-stimulated LI. These results were similar even when we defined each group based on a cut-off value of 4 for basal LI. Conclusions: Although PA patients in U to B group had worse surgical outcomes than did those in U to U group, basal LI could discriminate among patients with better surgical outcomes in U to B group.
AB - Objectives: We investigated the clinical significance of ACTH stimulation during adrenal venous sampling (AVS) by surgical outcome of primary aldosteronism (PA). Design: Multicenter retrospective study by Japan PA study. Method: We allocated 314 patients with both basal and ACTH-stimulated AVS data who underwent adrenalectomy to three groups: basal lateralization index (LI) ≥2 with ACTH-stimulated LI ≥4 on the ipsilateral side (Unilateral (U) to U group, n = 245); basal LI <2 with ACTH-stimulated LI ≥4 (Bilateral (B) to U group, n = 15); and basal LI ≥2 with ACTH-stimulated LI <4 (U to B group, n = 54). We compared surgical outcomes among the groups using the Primary Aldosteronism Surgical Outcome (PASO) criteria. Results: Compared with U to U group, U to B group had poor clinical and biochemical outcomes and low rates of adrenal adenoma as pathological findings (P = 0.044, 0.006, and 0.048, respectively), although there were no significant differences between U to U and B to U groups. All patients in U to B group with clinical and biochemical benefits, however, had adrenal adenoma as pathological findings and could be well differentiated from those with poor surgical outcomes via basal LI (>8.3), but not ACTH-stimulated LI. These results were similar even when we defined each group based on a cut-off value of 4 for basal LI. Conclusions: Although PA patients in U to B group had worse surgical outcomes than did those in U to U group, basal LI could discriminate among patients with better surgical outcomes in U to B group.
UR - http://www.scopus.com/inward/record.url?scp=85079111512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079111512&partnerID=8YFLogxK
U2 - 10.1530/EJE-19-0860
DO - 10.1530/EJE-19-0860
M3 - Article
C2 - 32038030
AN - SCOPUS:85079111512
SN - 0804-4643
VL - 182
SP - 265
EP - 273
JO - European journal of endocrinology
JF - European journal of endocrinology
IS - 3
ER -